Derm.city is pleased to announce the 2nd annual short essay competition on the topic of Inclusivity, Diversity and Equity in Dermatology. The contest is open to any qualified resident enrolled in a dermatology training program at a Canadian medical school.
This essay competition is organized by the Dermatology Industry Taskforce on Inclusion, Diversity and Equity (DiTiDE), an unincorporated, "ad hoc" committee consisting of Canadian life sciences managers and executives, physicians, and allied parties who are committed to improving the patient experience and outcomes of underrepresented skin types in Canadian Dermatology, through physician education, resources, and industry support.
To enter, applicants should write and submit an original short (350 to 500 words) essay on a topic of your choice relating to skin of colour and Inclusivity, Diversity and Equity in Dermatology. The essay could be ab0ut observations made during your medical training, your personal experience, or be aspirational regarding improved dermatologic care for these members of Canadian society. Entries may be submitted in French or English.
Six finalists will be selected, with each finalist receiving a dermatology textbook prize (digital or print), publication of the winning entries on the derm.city website and in the print journal The Chronicle of Skin & Allergy, plus additional benefits to be annouced.
All submissions to the competition must include:
Your name
University
Telephone number
Email address
All entries must be submitted via email to: admin@derm.city
The deadline for submissions has been extended to Nov. 4, 2023
Terms of entry:
The entrant must be a confirmed full-time dermatology resident in a Canadian medical school. You will need to provide a letter from your Program Director acknowledging they are aware of and approve the submission. Original entries can be submitted in English or French as Word or PDF attachments, or as web links to Word and PDF documents. The word count per entry is 350 to 500 words, not including the title. To ensure confidentiality, patients and anyone else described in the essay must remain anonymous, with the exception of the narrator. Multiple submissions will not be considered. The decision of the judges is final.